Session 2: Donor Selection

Moderator(s)

• 

  Jasleen Kukreja, MD

  Professor of Surgery
  University of California, San Francisco
  San Francisco, California, United States

  Disclosure(s): Guidepoint Consulting: Consultant (Ongoing); Lung Bioengineering: Advisory Board (Terminated, August 31, 2023)
• 

  Matthew Hartwig, MD (he/him/his)

  Professor of Surgery
  Duke University Medical Center
  Durham, North Carolina, United States

  Disclosure(s): Biomedinnovations: Consultant (Ongoing); CSL Behring: Advisory Board (Ongoing); Paragonix: Consultant (Terminated, October 16, 2023); Transmedics Inc: Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentations:

• 10:20 AM - 10:35 AM CT

  Size Matching and Donor Organ Quality Assessment
  

  Invited Speaker: Kewal Krishan, MD – Temple University Hospital, Philadelphia
• 10:35 AM - 10:50 AM CT

  Appropriate Use of Marginal Donors
  

  Invited Speaker: Michael S. Mulligan, MD (he/him/his) – University of Washington Medical Center
• 10:50 AM - 11:05 AM CT

  Organ Procurement Techniques—DBD, DCD, or NRP
  

  Invited Speaker: Sandra Lindstedt, MD, PhD – Lund University Hospital
• 11:05 AM - 11:20 AM CT

  Ex Vivo Lung Perfusion Platforms
  

  Invited Speaker: Kenneth R. McCurry, MD (he/him/his) – Cleveland Clinic
• 11:20 AM - 11:35 AM CT

  Hepatitis-C and Other Increased Risk Donors
  

  Invited Speaker: Errol L. Bush, MD (he/him/his) – Johns Hopkins
• 11:35 AM - 11:50 AM CT

  Panel Discussion